VINC
NASDAQVincerx Pharma Inc.
Price$0.10+0.00 (+0.00%)
2026-01-152026-04-21
Latest news
25 items- SECAmendment: SEC Form SCHEDULE 13G/A filed by Vincerx Pharma Inc.SCHEDULE 13G/A - Vincerx Pharma, Inc. (0001796129) (Subject)
- SECSEC Form DEFA14A filed by Vincerx Pharma Inc.DEFA14A - Vincerx Pharma, Inc. (0001796129) (Filer)
- PRVincerx Pharma, Inc. Announces Additional Adjournment of Special Meeting - Urges Stockholders to Vote FOR Approval of Dissolution ProposalRevised Potential Distribution Range of $0.03 to $0.07 per sharebased on current estimates and assumptions Failure to approve Dissolution Proposal on a timely basis will result in continued operating costs and further reduce or eliminate any potential distributions to stockholders SAN MATEO, Calif., July 16, 2025 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (OTC:VINC) today announced that the re-convened Special Meeting of Stockholders to consider a proposal to approve the liquidation and dissolution of Vincerx (the "Dissolution Proposal"), which was originally scheduled for earlier today, has again been adjourned, this time until 10:00 a.m., Pacific time, on August 27, 2025 via li
- SECSEC Form DEFA14A filed by Vincerx Pharma Inc.DEFA14A - Vincerx Pharma, Inc. (0001796129) (Filer)
- SECSEC Form 8-K filed by Vincerx Pharma Inc.8-K - Vincerx Pharma, Inc. (0001796129) (Filer)
- PRVincerx Pharma, Inc. Urges Stockholders to Vote FOR Approval of Dissolution Proposal and Announces Potential Range for Distributions to StockholdersPotential Distribution Range of $0.04 to $0.08 per share of outstanding stock based on current estimates and assumptions, including timely approval of Distribution Proposal Failure to approve Dissolution Proposal will reduce or eliminate any potential distributions to stockholders SAN MATEO, Calif., July 07, 2025 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (OTC:VINC) today announced updated information regarding the Special Meeting of Stockholders of the Company (the "Special Meeting") to consider the proposal to approve the dissolution and liquidation of the Company pursuant to the Plan of Liquidation and Dissolution (the "Dissolution Proposal"). The Special Meeting was adjourned to 10:0
- SECSEC Form DEFA14A filed by Vincerx Pharma Inc.DEFA14A - Vincerx Pharma, Inc. (0001796129) (Filer)
- PRVincerx Pharma, Inc. Announces Adjournment of Special Meeting - Will Reconvene Meeting on July 16, 2025 to Secure Votes Needed to Approve Dissolution ProposalSAN MATEO, Calif., June 18, 2025 (GLOBE NEWSWIRE) -- Vincerx Pharma, Inc. (OTC:VINC) today announced that the Special Meeting of Stockholders to consider a proposal to approve the liquidation and dissolution of Vincerx (the "Dissolution Proposal"), which was originally scheduled for earlier today, has been adjourned until 10:00 a.m., Pacific time, on July 16, 2025 via live audio webcast at www.virtualshareholdermeeting.com/VINC2025SM2. The adjournment will allow Vincerx more time to solicit the votes needed to approve the Dissolution Proposal. Vincerx is urging ALL stockholders to vote IMMEDIATELY FOR the Dissolution Proposal. Vincerx's board of directors unanimously recommends that stoc
- SECSEC Form DEFA14A filed by Vincerx Pharma Inc.DEFA14A - Vincerx Pharma, Inc. (0001796129) (Filer)
- SECSEC Form 10-Q filed by Vincerx Pharma Inc.10-Q - Vincerx Pharma, Inc. (0001796129) (Filer)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by Vincerx Pharma Inc.SCHEDULE 13G/A - Vincerx Pharma, Inc. (0001796129) (Subject)
- SECSEC Form DEF 14A filed by Vincerx Pharma Inc.DEF 14A - Vincerx Pharma, Inc. (0001796129) (Filer)
- SECSEC Form EFFECT filed by Vincerx Pharma Inc.EFFECT - Vincerx Pharma, Inc. (0001796129) (Filer)
- SECSEC Form EFFECT filed by Vincerx Pharma Inc.EFFECT - Vincerx Pharma, Inc. (0001796129) (Filer)
- SECSEC Form EFFECT filed by Vincerx Pharma Inc.EFFECT - Vincerx Pharma, Inc. (0001796129) (Filer)
- SECSEC Form S-8 POS filed by Vincerx Pharma Inc.S-8 POS - Vincerx Pharma, Inc. (0001796129) (Filer)
- SECSEC Form S-8 POS filed by Vincerx Pharma Inc.S-8 POS - Vincerx Pharma, Inc. (0001796129) (Filer)
- SECSEC Form S-8 POS filed by Vincerx Pharma Inc.S-8 POS - Vincerx Pharma, Inc. (0001796129) (Filer)
- SECSEC Form S-8 POS filed by Vincerx Pharma Inc.S-8 POS - Vincerx Pharma, Inc. (0001796129) (Filer)
- SECSEC Form S-8 POS filed by Vincerx Pharma Inc.S-8 POS - Vincerx Pharma, Inc. (0001796129) (Filer)
- SECSEC Form POS AM filed by Vincerx Pharma Inc.POS AM - Vincerx Pharma, Inc. (0001796129) (Filer)
- SECSEC Form POS AM filed by Vincerx Pharma Inc.POS AM - Vincerx Pharma, Inc. (0001796129) (Filer)
- SECSEC Form POS AM filed by Vincerx Pharma Inc.POS AM - Vincerx Pharma, Inc. (0001796129) (Filer)
- SECSEC Form PRE 14A filed by Vincerx Pharma Inc.PRE 14A - Vincerx Pharma, Inc. (0001796129) (Filer)
- SECSEC Form 25 filed by Vincerx Pharma Inc.25 - Vincerx Pharma, Inc. (0001796129) (Filer)
VINC FAQ
7 questionsWhat does Vincerx Pharma Inc. do?
Vincerx Pharma, Inc., a clinical-stage biopharmaceutical company, researches and develops new therapies to address unmet medical needs for the treatment of cancer. The company's lead product candidate is VIP152 that is in Phase I clinical trials to treat solid tumors. Its preclinical stage product candidates include VIP217 for solid tumors; VIP236 to treat multiple solid tumors; VIP943 for the treatment of leukemia and myelodysplastic syndrome; and VIP924 for treating B-cell malignancies. Vincerx Pharma, Inc. was founded in 2019 is based in Palo Alto, California.Where does VINC stock trade?
Vincerx Pharma Inc. (VINC) is listed on NASDAQ.What sector and industry is VINC in?
Vincerx Pharma Inc. operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry.When did Vincerx Pharma Inc. go public?
Vincerx Pharma Inc. (VINC) completed its IPO in 2025.What are analysts saying about VINC?
Vincerx Pharma Inc. has had 6 recent analyst actions on file. The most recent action was from HC Wainwright & Co.: Buy with a $2500.00 price target on 2022-01-14. Recent price targets range from $2400.00 to $3000.00.What companies are similar to VINC?
Notable peers in the same industry include LLY (Eli Lilly and Company), JNJ (Johnson & Johnson), AZN (AstraZeneca PLC), ABBV (AbbVie Inc.), MRK (Merck & Company Inc.). Compare VINC side-by-side with any of them on Quantisnow.How can I track VINC on Quantisnow?
Quantisnow aggregates Vincerx Pharma Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow VINC to receive live email and push alerts on every new disclosure.